Clinical Characteristics and Outcomes of Acute Kidney Injury in Patients with Severe Fever with Thrombocytopenia Syndrome

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2023 Oct 2

PMID 37779695

Authors

Zhongwei Zhang

Xue Hu

Qunqun Jiang

Wenjia Hu

Anling Li

Liping Deng

Yong Xiong

Affiliations

Soon will be listed here.

Abstract

Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging zoonosis caused by a novel bunyavirus. Until recently, the SFTS related acute kidney injury (AKI) was largely unexplored. This study aimed to investigate the clinical characteristics and outcomes of AKI in patients with SFTS.

Methods: The non-AKI and AKI groups were compared in terms of general characteristics, clinical features, laboratory parameters and cumulative survival rate. The independent risk factors for in-hospital mortality in patients with SFTS were analyzed by multivariate logistic regression to identify the population with poor prognosis.

Results: A total of 208 consecutive patients diagnosed with SFTS were enrolled, including 153 (73.6%) patients in the non-AKI group and 55 (26.4%) patients in the AKI group. Compared with patients without AKI, patients with AKI were older and had a higher frequency of diabetes. Among these laboratory parameters, platelet count, albumin and fibrinogen levels of patients with AKI were identified to be significantly lower than those of patients without AKI, while ALT, AST, ALP, triglyceride, LDH, BUN, uric acid, creatine, Cys-C, β2-MG, potassium, AMY, lipase, CK-MB, TnI, BNP, APTT, thrombin time, D-dimer, CRP, IL-6, PCT and ESR levels were significantly higher in patients with AKI. A higher SFTS viral load was also detected in the AKI patients than in the non-AKI patients. The cumulative survival rates of patients at AKI stage 2 or 3 were significantly lower than those of patients without AKI or at AKI stage 1. However, there was no significant difference in the cumulative survival rates between patients without AKI and those with stage 1 AKI. Univariate and multivariate binary logistic regression analyses demonstrated that stage 2 or 3 AKI was an independent risk factor for in-hospital mortality in patients with SFTS.

Conclusion: AKI is associated with poor outcomes in patients with SFTS, especially patients at AKI stage 2 or 3, who generally have high mortality. Our findings support the importance of early identification and timely treatment of AKI in patients with SFTS.

Citing Articles

Establishment and validation of a prognostic nomogram for severe fever with thrombocytopenia syndrome: A retrospective observational study.

Yang K, Wang Y, Huang J, Xiao L, Shi D, Cui D PLoS One. 2024; 19(10):e0311924.

PMID: 39446786 PMC: 11500966. DOI: 10.1371/journal.pone.0311924.

Acute kidney injury as a prognostic marker in severe fever with thrombocytopenia syndrome.

Lee J, Kim H, Lim M, Kim C, La Y, Jeon Y Sci Rep. 2024; 14(1):20651.

PMID: 39232049 PMC: 11374777. DOI: 10.1038/s41598-024-71438-8.

Machine learning-based risk prediction of acute kidney disease and hospital mortality in older patients.

Wang X, Xu L, Guan C, Xu D, Che L, Wang Y Front Med (Lausanne). 2024; 11:1407354.

PMID: 39211338 PMC: 11357947. DOI: 10.3389/fmed.2024.1407354.

Red Blood Cell Distribution Width Predicts Mortality in Hospitalized Patients with Severe Fever with Thrombocytopenia Syndrome.

Zhang S, Zhang Q, Wang J, Pan Y, Zhang Z, Geng Y J Inflamm Res. 2024; 17:4895-4904.

PMID: 39070134 PMC: 11277826. DOI: 10.2147/JIR.S468388.

References

Liu W, Lu Q, Cui N, Li H, Wang L, Liu K . Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis. 2013; 57(9):1292-9. DOI: 10.1093/cid/cit530. View

Jo H, Kim J, Hwang S, Seo J, Kim D, Yun N . Viral Load as a Factor Affecting the Fatality of Patients Suffering from Severe Fever with Thrombocytopenia Syndrome. Viruses. 2022; 14(5). PMC: 9144926. DOI: 10.3390/v14050881. View

Bagshaw S, Langenberg C, Haase M, Wan L, May C, Bellomo R . Urinary biomarkers in septic acute kidney injury. Intensive Care Med. 2007; 33(7):1285-1296. DOI: 10.1007/s00134-007-0656-5. View

Wong F, Reddy K, Tandon P, OLeary J, Garcia-Tsao G, Vargas H . Progression of Stage 2 and 3 Acute Kidney Injury in Patients With Decompensated Cirrhosis and Ascites. Clin Gastroenterol Hepatol. 2020; 19(8):1661-1669.e2. DOI: 10.1016/j.cgh.2020.08.025. View

Khadzhynov D, Schmidt D, Hardt J, Rauch G, Gocke P, Eckardt K . The Incidence of Acute Kidney Injury and Associated Hospital Mortality. Dtsch Arztebl Int. 2019; 116(22):397-404. PMC: 6676729. DOI: 10.3238/arztebl.2019.0397. View

Khalil J, Yamada S, Tsukamoto Y, Abe H, Shimojima M, Kato H . The Nonstructural Protein NSs of Severe Fever with Thrombocytopenia Syndrome Virus Causes a Cytokine Storm through the Hyperactivation of NF-B. Mol Cell Biol. 2020; 41(3):e0054220. PMC: 8088271. DOI: 10.1128/MCB.00542-20. View

Wang Y, Song Z, Wei X, Yuan H, Xu X, Liang H . Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2022; 16(6):e0010489. PMC: 9246219. DOI: 10.1371/journal.pntd.0010489. View

Gonsalez S, Cortes A, Silva R, Lowe J, Prieto M, Lara L . Acute kidney injury overview: From basic findings to new prevention and therapy strategies. Pharmacol Ther. 2019; 200:1-12. PMC: 10134404. DOI: 10.1016/j.pharmthera.2019.04.001. View

Wang L, Wan G, Shen Y, Zhao Z, Lin L, Zhang W . A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage-A multicenter study in China. PLoS Negl Trop Dis. 2019; 13(11):e0007829. PMC: 6934327. DOI: 10.1371/journal.pntd.0007829. View

10.

Gong L, Zhang L, Wu J, Lu S, Lyu Y, Zhu M . Clinical Progress and Risk Factors for Death from Severe Fever with Thrombocytopenia Syndrome: A Multihospital Retrospective Investigation in Anhui, China. Am J Trop Med Hyg. 2021; 104(4):1425-1431. PMC: 8045620. DOI: 10.4269/ajtmh.20-0270. View

11.

Liu S, Chai C, Wang C, Amer S, Lv H, He H . Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics. Rev Med Virol. 2013; 24(2):90-102. PMC: 4237196. DOI: 10.1002/rmv.1776. View

12.

Moledina D, Hall I, Thiessen-Philbrook H, Reese P, Weng F, Schroppel B . Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury. Am J Kidney Dis. 2017; 70(6):807-816. PMC: 5701867. DOI: 10.1053/j.ajkd.2017.06.031. View

13.

Cui N, Liu R, Lu Q, Wang L, Qin S, Yang Z . Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis. J Infect. 2014; 70(1):52-9. DOI: 10.1016/j.jinf.2014.08.001. View

14.

Yu X, Liang M, Zhang S, Liu Y, Li J, Sun Y . Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011; 364(16):1523-32. PMC: 3113718. DOI: 10.1056/NEJMoa1010095. View

15.

Bao C, Guo X, Qi X, Hu J, Zhou M, Varma J . A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis. 2011; 53(12):1208-14. DOI: 10.1093/cid/cir732. View

16.

Jin C, Liang M, Ning J, Gu W, Jiang H, Wu W . Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A. 2012; 109(25):10053-8. PMC: 3382536. DOI: 10.1073/pnas.1120246109. View

17.

Chen X, Cong M, Li M, Kang Y, Feng Y, Plyusnin A . Infection and pathogenesis of Huaiyangshan virus (a novel tick-borne bunyavirus) in laboratory rodents. J Gen Virol. 2012; 93(Pt 6):1288-1293. DOI: 10.1099/vir.0.041053-0. View

18.

Liu Q, He B, Huang S, Wei F, Zhu X . Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis. 2014; 14(8):763-772. DOI: 10.1016/S1473-3099(14)70718-2. View

19.

Luft F . Biomarkers and predicting acute kidney injury. Acta Physiol (Oxf). 2020; 231(1):e13479. DOI: 10.1111/apha.13479. View

20.

Li S, Li Y, Wang Q, Yu X, Liu M, Xie H . Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical finding in a fatal case. Virol J. 2018; 15(1):97. PMC: 5977472. DOI: 10.1186/s12985-018-1006-7. View